| Video

The current landscape of pain management is shifting. There’s a huge reaction to opioids and the negative impact they’ve had on many people’s lives. Alongside that, there’s a rise in the interest in cannabinoids. Might the legalization of marijuana ultimately reduce opioid deaths? How can pain...

| Video

Gary Jay, MD, FAAPM, a clinical professor at the University of North Carolina, discusses the all-time high interest in cannabinoids. Does this interest impact the perceived opioid crisis? Do we know enough about CBD and THC to make decisions? What are the facts? What about edibles for headaches?

| Article

In an online edition of the British Journal of Anaesthesia, the Perioperative Pain and Addiction Interdisciplinary Networkor PAINoutlined recommendations for patients who use cannabis. The regulation and use of marijuana products is constantly evolving. Cannabis use can alter perioperative...

| Article

A study in the Journal of the American Geriatrics Society of 568 people surveyed found that 15% used cannabis within the past 3 years, over 50% of those surveyed used it regularly (daily or weekly), and 78% used it for self-medicating. Patients reported most commonly smoking, taking tinctures, or...

| Video

Some practitioners are interested in learning more about cannabinoids, yet many are still hesitant. What’s new in controlled trials? How can the information be found? Theresa Mallick-Searle, MS, NP-BC, ANP-BC, discusses this plus the potential use of marijuana based meds in epilepsy and other...

| Article

Interest in cannabinoids is at an all-time high. Does this interest impact the perceived opioid crisis? Do we know enough about CBD and THC to make decisions? What has Dr. Jay experienced?

We don’t know enough to be certain of anything:

  • I personally hesitate to utilize and tell patients, “Oh...

| Article

The American Heart Association has issued a scientific statement calling for education for clinicians on the health implications of cannabis products. They are calling for funding and clinical trials, both of which are predicated on the removal of legal hurdles. The AHA states, “Our understanding of...

| Article

In a recent issue of the journal of Substance Use & Misuse, a study of sickle cell disease patients was discussed. It is well known that, in the sickle cell disease population, chronic pain rates are high. Perhaps less well known are the levels of mental health issues. Even less known? Levels of...

| Podcast

Marijuana and hemp are genetically distinct cousins of the genus Cannabis sativa L., yet they have been erroneously associated with each other for the past 80 years.

That all changed in December 2018 when Congress removed hemp from the federal Controlled Substances Act and legalized the plant and...

| Article

Newswise — Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Director of Pain Services, Toronto General Hospital, and a recognized leader in educating Canadians about chronic pain management and the risk factors of...

Subscribe to cannabinoids

Sign-Up